Research focuses on its ability to upregulate the expression of vital tight-junction proteins (such as claudins, occludins, and zonula occludens-1), thereby minimizing luminal permeability while simultaneously boosting local mucus synthesis and stimulating vitamin D3 receptor expression

When to use IM injection Intramuscular is better when: Treating deep muscle injuries Want faster absorption Prefer muscle over fat injection Targeting specific muscle groups Most people use SubQ: SubQ is easier and works well IM not necessary for most BPC-157 uses IM more painful typically IM injection sites Best muscles: Glutes (butt, upper outer quadrant) Thighs (vastus lateralis - outer mid-thigh) Deltoids (shoulder muscle - advanced) Site selection: Choose muscle near injury if targeting specific area Rotate between muscles Requires longer needle than SubQ IM injection technique Different from SubQ: Longer needle (1-1.5 inch) 90-degree angle (straight in) Into muscle, not just under skin Inject slowly May feel more discomfort Not necessary for most BPC-157 users: SubQ works great
[2] This increase in MMP-2 was also accompanied by a rise in MMP-2 mRNA levels, indicating that GHK-Cu potentially enhances MMP-2 expression at the transcriptional level
Overall, we noted that the applicant indicated that the technology does not offer a treatment option for patients unresponsive to or ineligible for currently available treatments, stating that the same patient population could be treated using a reusable, reprocessed cystoscope